Story thread · 2 reports / 2 sources
Potential liver safety issue seen in phase 3 trial for Bristol's admilparant
seekingalpha.com · 21h · first report
How the coverage leans
Across 2 sources · syndicated copies counted once
The coverage
- Bristol Myers trial revisions shake confidence in new class of fibrosis drugs
biopharmadive.com · 2h
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.